1. Home
  2. ANDE vs AUPH Comparison

ANDE vs AUPH Comparison

Compare ANDE & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • AUPH
  • Stock Information
  • Founded
  • ANDE 1947
  • AUPH 1993
  • Country
  • ANDE United States
  • AUPH Canada
  • Employees
  • ANDE N/A
  • AUPH N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANDE Industrials
  • AUPH Health Care
  • Exchange
  • ANDE Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • ANDE 1.3B
  • AUPH 999.8M
  • IPO Year
  • ANDE N/A
  • AUPH 1999
  • Fundamental
  • Price
  • ANDE $34.41
  • AUPH $8.11
  • Analyst Decision
  • ANDE Buy
  • AUPH Strong Buy
  • Analyst Count
  • ANDE 3
  • AUPH 2
  • Target Price
  • ANDE $51.67
  • AUPH $11.50
  • AVG Volume (30 Days)
  • ANDE 294.2K
  • AUPH 966.4K
  • Earning Date
  • ANDE 05-06-2025
  • AUPH 05-12-2025
  • Dividend Yield
  • ANDE 2.48%
  • AUPH N/A
  • EPS Growth
  • ANDE N/A
  • AUPH N/A
  • EPS
  • ANDE 3.32
  • AUPH 0.04
  • Revenue
  • ANDE $11,198,429,000.00
  • AUPH $235,133,000.00
  • Revenue This Year
  • ANDE $5.97
  • AUPH $11.86
  • Revenue Next Year
  • ANDE $4.31
  • AUPH $24.96
  • P/E Ratio
  • ANDE $9.48
  • AUPH $203.75
  • Revenue Growth
  • ANDE N/A
  • AUPH 33.97
  • 52 Week Low
  • ANDE $31.03
  • AUPH $4.98
  • 52 Week High
  • ANDE $55.52
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 37.50
  • AUPH 52.49
  • Support Level
  • ANDE $31.03
  • AUPH $7.92
  • Resistance Level
  • ANDE $38.08
  • AUPH $8.38
  • Average True Range (ATR)
  • ANDE 1.30
  • AUPH 0.23
  • MACD
  • ANDE -0.32
  • AUPH 0.03
  • Stochastic Oscillator
  • ANDE 39.86
  • AUPH 63.01

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: